Related content

Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma

By Ohnishi Yuichi   Inoue Hiroshi   Furukawa Masayuki   Kakudo Kenji   Nozaki Masami  

Oncology Reports, Vol. 27, Iss. 4, 2012-04 ,pp. : 954-958

Spandidos Publications

Access to resources Recommend Favorite

Gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27 KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines

By Shintani S.   Li C.   Mihara M.   Yano J.   Terakado N.   Nakashiro K.-i.   Hamakawa H.  

Oral Oncology, Vol. 40, Iss. 1, 2004-01 ,pp. : 43-51

Elsevier

Access to resources Recommend Favorite

Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition

By                

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 201-207

Spandidos Publications

Access to resources Recommend Favorite

Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2

By                    

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1799-1807

Spandidos Publications

Access to resources Recommend Favorite

Paclitaxel induces apoptosis and reduces proliferation by targeting epidermal growth factor receptor signaling pathway in oral cavity squamous cell carcinoma

By Hu Jing   Zhang Na   Wang Ronglin   Huang Fei   Li Guang  

Oncology Letters, Vol. 10, Iss. 4, 2015-10 ,pp. : 2378-2384

Spandidos Publications

Access to resources Recommend Favorite